Cancer Clinical Trials | Research Pipeline Overview | US & International
Clinical trials play a central role in the evolution of oncology evidence. They are research studies that test new treatments, procedures, or devices to determine their safety and effectiveness.
This page provides an educational overview of oncology clinical trials referenced in public research registries, including studies of mRNA vaccines, CAR-T cell therapies, immunotherapy, and other investigational approaches to support understanding.
Important Notice:
This page provides an educational overview of oncology clinical research as reported in public registries. It does not provide medical advice, trial recruitment, enrollment assistance, referrals, or care navigation.
Eligibility, participation, and treatment decisions must be determined by qualified healthcare professionals and trial investigators.
Clinical Trial Intelligence
A curated, continuously updated index of oncology clinical trials organized to support discovery, landscape understanding, and research planning.
How experimental oncology research is studied, reported, and evaluated across Phase I–IV trials
Educational overview of oncology clinical trials referenced in public research registries, including studies of mRNA vaccines, CAR-T cell therapies, immunotherapy, and other investigational approaches to support understanding.
Clinical Trial Intelligence
Clinical trials play a central role in the evolution of oncology evidence. Clinical Trial Intelligence is designed to improve visibility into research activity, therapeutic development, emerging interventions, and changing areas of scientific focus across cancer research ecosystems.
Rather than focusing on individual studies in isolation, Clinical Trial Intelligence seeks to provide structured context around how oncology research evolves across diseases, therapies, biomarkers, and scientific priorities.
Framework
Core Clinical Trial Intelligence Areas
Four structured lenses for understanding how oncology research evolves across diseases, therapies, and priorities.
Trial Activity
Explore patterns in oncology clinical trial activity across cancer types, therapeutic categories, and evolving research priorities.
Therapeutic Development
Examine areas of emerging treatment investigation, novel interventions, and changing therapeutic approaches.
Research Momentum
Monitor areas of accelerating clinical research activity and shifting scientific focus.
Emerging Opportunities
Identify developing areas of oncology investigation, unmet needs, and future directions of clinical research.
Research Inquiry
Questions Clinical Trial Intelligence Can Help Explore
Where is clinical trial activity accelerating?
Which cancers are attracting increasing research attention?
Which therapies are entering clinical investigation?
Where are evidence gaps driving new trials?
Which biomarkers are associated with emerging trial activity?
How are oncology research priorities evolving over time?
Important Research Context Notice
This page provides an educational overview of oncology clinical research as reported in public registries. It does not provide medical advice, trial recruitment, enrollment assistance, referrals, or care navigation.
Eligibility, participation, and treatment decisions must be determined by qualified healthcare professionals and trial investigators.
Status reflects most recent public registry update and may not reflect real-time enrollment or protocol changes.
Representative trials publicly listed in registries. Illustrative, not exhaustive. Examples of ongoing and recent research activity.
Dataset last refreshed: 2/18/2026
0 Active US Clinical Trials on Page 1
Referenced in public trial registries • 1000 records per page
Trial Categorization: Trials are programmatically categorized into US vs International using sponsor and study location metadata. If sponsor/locations change in the registry, categorization may update at the next refresh.
Note on Trial IDs: Trial IDs shown are representative and illustrative. In production deployment, each trial would have a globally unique identifier with registry-namespace prefixing (e.g., NCT-, EUCTR-, ChiCTR-) to ensure no duplication.
Understanding Clinical Trials in Oncology Research
Educational overview of how experimental oncology research is studied and evaluated across cancer types and trial phases
✓ US & International trials • Public registry records • Evidence context overview